Restart Life Sciences Corp.
Restart Life Sciences Corp.
CSE Index:
Currency:
Restart Life Sciences Corp. is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome.
Restart Life Sciences Corp. (HEAL)
SEDAR Information
Company Info
Address
700-838 W Hastings Street
Vancouver, BC V6C 0A6
CanadaPhone
778-819-0244Email
hello@restartlife.coWebsite
https://www.restartlife.coListing date
Tuesday, February 10, 2015Transfer Agent
Olympia Trust CompanyEmail
hello@restartlife.coAuditor
Kreston GTA LLPCapitalization
Issued & Outstanding:
36293901Reserved for Issuance:
829600Company Officers
Steve Loutskou, Chief Executive Officer
Kelly Pladson, Corporate Secretary
Rebecca Hudson, Chief Financial Officer
Derek Ivany, Executive Chair
Bulletins
17/12/2024
2024-1227 - Symbol Change - Removal of Inactive Designation - Restart Life Sciences Corp. (HEAL)
Le 17 décembre/December 2024
Further to bulletin 2024-1207, the Exchange has determined that Restart Life Sciences Corp. has now met the continued listing requirements.
In accordance with Policy 3, section 5.1, the .X extension will be removed from the symbol.
